Urinary Tubular Biomarkers for Chronic Kidney Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorErasmus Medical Center

About this trial

Currently used tests for chronic kidney injury only assess the function of one part of the kidney: the filter called the glomerulus. The other part, called the tubule, is disregarded. Based on many previous studies, the investigators have good reason to assume that a better prediction of the course of chronic kidney disease by testing tubular function will be possible. This is important, for example, when patients need to be treated with kidney-protecting drugs.

Eligibility criteria

Qualifiers

Chronic kidney disease stage 3 (eGFR 30-59ml/min)

Disqualifiers

Active glomerulonephritis treated with immunosuppression

Kidney transplant recipient

Current treatment with chemo- or immunotherapy for malignancy

Trial design

Treatments tested in this trial

  • Urinary tubular test panel

Treatment groups

No treatment groups listed

Locations

1
Erasmus MC3015 GD, RotterdamSouth Holland, Netherlands

Sponsors and collaborators

Erasmus Medical Center

Lead sponsor